Holen Sie sich die Stockscreener-App
10.86
0.18%
0.02
Handel nachbörslich:
10.65
-0.21
-1.93%
Upstream Bio Inc Aktie (UPB) Neueste Nachrichten
Upstream Bio to Participate in the Goldman Sachs 46th Annual Global Healthcare Conference - The Manila Times
Upstream Bio to Reveal Latest Inflammatory Disease Treatment Progress at Major Goldman Sachs Conference - Stock Titan
MIRAE ASSET GLOBAL ETFS HOLDINGS Ltd. Purchases New Position in Upstream Bio, Inc. (NASDAQ:UPB) - Defense World
Deutsche Bank AG Invests $244,000 in Upstream Bio, Inc. (NASDAQ:UPB) - Defense World
Northern Trust Corp Makes New Investment in Upstream Bio, Inc. (NASDAQ:UPB) - Defense World
Jane Street Group LLC Takes Position in Upstream Bio, Inc. (NASDAQ:UPB) - Defense World
Upstream Bio names new chief technology officer By Investing.com - Investing.com South Africa
Upstream Bio names new chief technology officer - Investing.com Australia
Upstream Bio Appoints Stacy Price as Chief Technology Officer - GlobeNewswire
Upstream Bio, Inc. Appoints Stacy Price as Chief Technology Officer to Lead Expansion of Technical Operations - Nasdaq
Upstream Bio Strengthens Leadership Team: Former Invivyd Executive Takes CTO Role for Critical Clinical Program - Stock Titan
Upstream Bio Leads Life Sciences IPOs With Upsized Listing - MSN
Tower Research Capital LLC TRC Takes Position in Upstream Bio, Inc. (NASDAQ:UPB) - Defense World
Is Upstream Bio Inc (NASDAQ: UPB) A Good Investment Now? - Stocksregister
Wells Fargo & Company MN Invests $149,000 in Upstream Bio, Inc. (NASDAQ:UPB) - Defense World
27,017 Shares in Upstream Bio, Inc. (NASDAQ:UPB) Acquired by Barclays PLC - Defense World
MetLife Investment Management LLC Invests $181,000 in Upstream Bio, Inc. (NASDAQ:UPB) - Defense World
Brokers Offer Predictions for Upstream Bio Q2 Earnings - Defense World
Metric Analysis: Upstream Bio Inc (UPB)’s Key Ratios in the Limelight - DWinneX
Upstream Bio Advances Verekitug in Clinical Trials - TipRanks
Upstream Bio, Inc.: Strong Buy Rating Driven by Promising Drug Progress and Solid Financial Position - TipRanks
Upstream Bio reports Q1 revenue $566k, consensus $326.25k - TipRanks
Upstream Bio Reports First Quarter 2025 Financial Results and Accelerates Guidance on All Clinical Programs - GlobeNewswire
Transpire Bio Announces R&D and Manufacturing Expansion - The Manila Times
Upstream Bio Fast-Tracks Clinical Trials: Key Data Coming Earlier for Revolutionary Respiratory Drug - Stock Titan
Invesco Ltd. Buys Shares of 15,602 Upstream Bio, Inc. (NASDAQ:UPB) - Defense World
1,734 Shares in Upstream Bio, Inc. (NASDAQ:UPB) Purchased by Legal & General Group Plc - Defense World
JPMorgan Chase & Co. Acquires Shares of 47,792 Upstream Bio, Inc. (NASDAQ:UPB) - Defense World
LPL Financial LLC Cuts Stake in Invesco FTSE RAFI Developed Markets ex-U.S. Small-Mid ETF (NYSEARCA:PDN) - Defense World
Geode Capital Management LLC Purchases New Position in Upstream Bio, Inc. (NASDAQ:UPB) - Defense World
Upstream Bio Inc’s Banking’s 100-Day Moving Average at 11.87: Will the Stock Break Through? - investchronicle.com
Medical Properties Trust Inc (MPW) Stock: Navigating a Year of Volatility - investchronicle.com
CytomX Therapeutics Inc’s Shares Reel: -10.73% Quarterly Revenue Decline Amid 60.07M Market Cap - investchronicle.com
Philip Morris International Inc (PM) Stock: Uncovering 52-Week Market Trends - investchronicle.com
Upstream Bio: Verekitug, A Longer-Acting Dupixent?Key Data Is Imminent - Seeking Alpha
Corebridge Financial Inc. Takes Position in Upstream Bio, Inc. (NASDAQ:UPB) - Defense World
Amylyx Pharmaceuticals, Inc. (NASDAQ:AMLX) Shares Purchased by American Century Companies Inc. - Defense World
Old Dominion Freight Line (NASDAQ:ODFL) Given New $188.00 Price Target at Stifel Nicolaus - Defense World
Chronic Rhinosinusitis with Nasal Polyps Market to Expand Significantly by 2034, States DelveInsight Report | AstraZeneca, Amgen, Keymed Biosciences, GlaxoSmithKline, Genentech, Inc, Novartis - Barchart.com
Upstream Bio (NASDAQ:UPB) Is In A Good Position To Deliver On Growth Plans - Yahoo Finance
Amtech Systems, Tesla And Other Big Stocks Moving Lower In Thursday's Pre-Market Session - Benzinga
12 Health Care Stocks Moving In Thursday's Pre-Market Session - Benzinga
Upstream's IPO Lockup Period Expires, RSLS Partners With Israel-based Motion, PVLA On Watch - RTTNews
Why ReShape Lifesciences Shares Are Trading Higher By Over 82%; Here Are 20 Stocks Moving Premarket - Benzinga
Certain Common Stock of Upstream Bio, Inc. are subject to a Lock-Up Agreement Ending on 9-APR-2025. - marketscreener.com
Upstream Bio, Inc.’s Lock-Up Period Will Expire on April 9th (NASDAQ:UPB) - Defense World
Charles Schwab Investment Management Inc. Invests $2.23 Million in Upstream Bio, Inc. (NASDAQ:UPB) - Defense World
Bank of New York Mellon Corp Invests $607,000 in Upstream Bio, Inc. (NASDAQ:UPB) - Defense World
Severe Asthma Clinical Trials and Studies 2025: EMA, PDMA, FDA - openPR.com
Upstream Bioprocessing Market Size, Industry Demand And Report Insights By 2033 - Straits Research
1,660 Shares in Upstream Bio, Inc. (NASDAQ:UPB) Acquired by US Bancorp DE - Defense World
US Bancorp DE Sells 4,285 Shares of SunOpta Inc. (NASDAQ:STKL) - The AM Reporter
Upstream Bio, Inc.: Promising Outlook with Strategic Positioning and Strong Trial Execution - TipRanks
William Blair Lifts Earnings Estimates for Upstream Bio - Defense World
0.00%
0.54%
In Yahoo öffnen
|
In Google öffnen
|
In Finviz öffnen
|
In MarketWatch öffnen
|
Öffnen Sie in EDGAR
|
Offen in Reuters
Kapitalisierung:
|
Volumen (24h):